Showing results (191-200 of 260) with videos related to
Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2016
Butyrophilin 3A/CD277-Dependent Activation of Human γδ T Cells: Accessory Cell Capacity of Distinct Leukocyte PopulationsPatrik Theodor Nerdal, Christian Peters, Hans-Heinrich Oberg, et al.Experimental Hematology|November 13, 2004
CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantationMohamad Mohty, Sophie Bagattini, Christian Chabannon, et al.Cell Death & Disease|October 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killingFrancesca Barberini, Riccardo Pietroni, Simone Ielpo, et al.Oncoimmunology|November 20, 2019
HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanomaNausicaa Malissen, Nicolas Macagno, Samuel Granjeaud, et al.Oncoimmunology|May 4, 2016
A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavageColette Dezutter-Dambuyant, Isabelle Durand, Laurent Alberti, et al.Oncoimmunology|March 5, 2016
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceAlessandra Dondero, Fabio Pastorino, Mariella Della Chiesa, et al.The Journal of Clinical Investigation|August 16, 2011
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunityEmilie Mamessier, Aude Sylvain, Marie-Laure Thibult, et al.STAR Protocols|October 21, 2022
High-throughput mass cytometry staining for deep phenotyping of human natural killer cellsAmira Ben Amara, Marie-Sarah Rouviere, Stéphane Fattori, et al.Journal for Immunotherapy of Cancer|May 25, 2023
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumorsClémence Demerlé, Laurent Gorvel, Marielle Mello, et al.Communications Medicine|February 11, 2026
Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomyJonathan Garnier, Grégoire Bellan, Anaïs Palen, et al.Pageof 26